Sign in

CIK 0001390478

  • Non-accelerated filer
  • Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-200-5278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$716,682
in 3 filings

Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2013-11-26 SCHWARTZ MARK W. Chief Operating Officer Grant or award · Stock Option (right to buy) +300,000 300,000
2013-11-26 Ahn Mark J President and CEO Grant or award · Stock Option (right to buy) +600,000 600,000
2013-11-26 Ahn Mark J President and CEO Grant or award · Stock Option (right to buy) +200,000 200,000
2013-11-26 Nisi Rudolph Director Grant or award · Stock Option (right to buy) +200,000 200,000
2013-11-12 Hillsberg Sanford Director Gift −37,001 93,375
2013-10-11 Hillsberg Sanford Director Grant or award +2,630 17,974
2013-10-11 SCHWARTZ MARK W. EVP, Chief Operating Officer Grant or award +7,349 504,009
2013-06-30 Ahn Mark J President & CEO Other acquisition +7,862 $1.35 $11K 108,108
2013-06-30 SCHWARTZ MARK W. EVP, Chief Operating Officer Other acquisition +7,862 $1.35 $11K 496,660
2013-06-30 Dunlap Ryan Principal Accounting Officer Other acquisition +1,369 $1.35 $2K 2,615
2013-06-04 Hillsberg Sanford Director Grant or award +9,344 145,720
2013-06-04 SCHWARTZ MARK W. EVP, Chief Operating Officer Grant or award +26,110 488,798
2013-06-04 Hillsberg Sanford Director Grant or award +9,327 145,703
2013-04-26 Ashton William Director Grant or award · Stock Option (right to buy) +100,000 100,000
2013-01-29 Nisi Rudolph Director Grant or award · Stock Option (right to buy) +50,000 50,000
2013-01-29 Chin Richard Director Grant or award · Stock Option (right to buy) +50,000 50,000
2013-01-29 GALLIKER STEPHEN S Director Grant or award · Stock Option (right to buy) +50,000 50,000
2013-01-29 Ahn Mark J President & CEO Grant or award · Stock Option (right to buy) +650,000 650,000
2013-01-29 SCHWARTZ MARK W. EVP, Chief Operating Officer Grant or award · Stock Option (right to buy) +250,000 250,000
2013-01-29 MAZANET ROSEMARY Chief Medical Officer Grant or award · Stock Option (right to buy) +450,000 450,000

Page 18 of 29 · 580 trades